載入...
Three cases of treatment with nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy
No effective treatment for COVID-19 has been well established yet. Nafamostat, known as anticoagulant, has potential anti-inflammatory and anti-viral activities against COVID-19. We report three cases of COVID-19 pneumonia who progressed while using antiviral drugs and needed supplementary oxygen th...
Na minha lista:
| 發表在: | Int J Infect Dis |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7250091/ https://ncbi.nlm.nih.gov/pubmed/32470602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2020.05.072 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|